Sponsored Links

Genitope stops cancer vaccine program, looking at finances

March 10 | Mon Mar 10, 2008 4:59pm EDT

March 10 (Reuters) - Genitope Corp GTOP.O said it will stop the development of its cancer vaccine MyVax, which failed late-stage trials last year.

The company said it is evaluating its financial position and plans for continued operations. (Reporting by Varsha Tickoo in Bangalore; Editing by Anil D'Silva)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.